
Macglim M 1mg/500mg Tablet SR
Marketer
Shamac Health Care Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Macglim M 1mg/500mg Tablet SR
Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan that includes dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, will be recommended by your doctor.
Uses of Macglim M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Macglim M 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Macglim M 1mg/500mg Tablet SR should be administered with a meal.
Common Side effects of Macglim M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Macglim M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Macglim M 1mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with food.
How Macglim M 1mg/500mg Tablet SR works:
Macglim M 1mg/500mg Extended-Release Tablets contain glimepiride and metformin, two anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Macglim M 1mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Macglim M 1mg/500mg sustained-release tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing this medication. Seek medical advice before use.
Breast feedingUNSAFE
Extended-release Macglim M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Macglim M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Medical consultation is recommended. Macglim M 1mg/500mg Tablet SR is contraindicated in those with severe kidney disease. Routine kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Macglim M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. For individuals with mild to moderate liver disease, initiation should be at a low dose; use is contraindicated in those with severe liver disease.
What if you forget to take Macglim M 1mg/500mg Tablet SR :
Should you forget to take your Macglim M 1mg/500mg SR tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Macglim M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
